Company profile for Gaeta Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Gaeta Therapeutics was founded by the University of Zurich in 2017 as a vehicle for the commercialisation of its immuno-oncology patent estate, relating to the use of Interleukin-12 (IL-12) in combination with checkpoint blockers in the treatment of cancer. Gaeta’s patent portfolio protects the use of locally delivered IL-12, whether through protein/fusion protein, nucleic acid or oncoviral expression, in combination with CT...
Gaeta Therapeutics was founded by the University of Zurich in 2017 as a vehicle for the commercialisation of its immuno-oncology patent estate, relating to the use of Interleukin-12 (IL-12) in combination with checkpoint blockers in the treatment of cancer. Gaeta’s patent portfolio protects the use of locally delivered IL-12, whether through protein/fusion protein, nucleic acid or oncoviral expression, in combination with CTLA4, PD1 or PDL1 checkpoint blockade. This Intellectual Property is available for license and Gaeta Therapeutics is presently finalising a worldwide framework of exclusive and non-exclusive licenses.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Lewis House, 56 Manchester Road, Altrincham, Cheshire WA14 4PJ
Telephone
Telephone
+44 7771 802713
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty